Stride, Inc.
Stride, Inc. (LRN) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Stride, Inc. (LRN), featuring income statements, balance sheets, and cash flow data.
Stride, Inc. (LRN) Income Statement & Financial Overview
View the income breakdown for Stride, Inc. LRN across both annual and quarterly reports.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $613.38M | $587.21M | $551.08M | $534.18M |
| Cost of Revenue | $364.09M | $347.35M | $335.23M | $345.97M |
| Gross Profit | $249.29M | $239.86M | $215.85M | $188.21M |
| Gross Profit Ratio | $0.41 | $0.41 | $0.39 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $118.50M | $114.76M | $168.51M | $114.53M |
| Operating Expenses | $118.50M | $114.76M | $168.51M | $114.53M |
| Total Costs & Expenses | $482.59M | $462.11M | $503.74M | $460.50M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $2.67M | $2.35M | $2.32M |
| Depreciation & Amortization | $28.94M | $27.39M | $28.13M | $27.52M |
| EBITDA | $167.09M | $159.82M | $83.46M | $108.72M |
| EBITDA Ratio | $0.27 | $0.27 | $0.15 | $0.20 |
| Operating Income | $130.79M | $125.10M | $47.34M | $73.68M |
| Operating Income Ratio | $0.21 | $0.21 | $0.09 | $0.14 |
| Other Income/Expenses (Net) | $4.57M | $4.66M | $6.42M | $5.20M |
| Income Before Tax | $135.36M | $129.76M | $53.77M | $78.88M |
| Income Before Tax Ratio | $0.22 | $0.22 | $0.10 | $0.15 |
| Income Tax Expense | $35.45M | $33.36M | $11.28M | $16.10M |
| Net Income | $99.35M | $96.39M | $40.88M | $62.78M |
| Net Income Ratio | $0.16 | $0.16 | $0.07 | $0.12 |
| EPS | $2.31 | $2.24 | $0.95 | $1.47 |
| Diluted EPS | $1.98 | $2.03 | $0.94 | $1.42 |
| Weighted Avg Shares Outstanding | $43.09M | $43.02M | $42.87M | $44.29M |
| Weighted Avg Shares Outstanding (Diluted) | $49.18M | $47.46M | $43.71M | $44.25M |
Over the past four quarters, Stride, Inc. demonstrated steady revenue growth, increasing from $534.18M in Q4 2024 to $613.38M in Q3 2025. Operating income reached $130.79M in Q3 2025, maintaining a consistent 21% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $167.09M, reflecting operational efficiency. Net income rose to $99.35M, with EPS at $2.31. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan